0001882697-21-000001.txt : 20210915 0001882697-21-000001.hdr.sgml : 20210915 20210915160921 ACCESSION NUMBER: 0001882697-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210915 DATE AS OF CHANGE: 20210915 EFFECTIVENESS DATE: 20210915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Via Nova Therapeutics, Inc. CENTRAL INDEX KEY: 0001882697 IRS NUMBER: 862573903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-413505 FILM NUMBER: 211255525 BUSINESS ADDRESS: STREET 1: 1111 BROADWAY STREET 2: SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 BUSINESS PHONE: 510-227-2102 MAIL ADDRESS: STREET 1: 1111 BROADWAY STREET 2: SUITE 1300 CITY: OAKLAND STATE: CA ZIP: 94607 D 1 primary_doc.xml X0708 D LIVE 0001882697 Via Nova Therapeutics, Inc. 1111 BROADWAY SUITE 1300 OAKLAND CA CALIFORNIA 94607 510-227-2102 DELAWARE None None Corporation true 2020 Donald Ganem C/O VIA NOVA THERAPEUTICS, INC. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 Executive Officer Director Joseph Jimenez C/O VIA NOVA THERAPEUTICS, INC. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 Director Ilan Zipkin C/O VIA NOVA THERAPEUTICS, INC. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 Director Benjamine Liu C/O VIA NOVA THERAPEUTICS, INC. 1111 BROADWAY, SUITE 1300 OAKLAND CA CALIFORNIA 94607 Director Biotechnology Decline to Disclose 06b false 2021-08-31 false true false 0 5000001 5000001 0 false 2 0 0 0 false Via Nova Therapeutics, Inc. /s/ Donald Ganem Donald Ganem President 2021-09-15